Published: 2021-12-28

Relationship between anxiety, depression and quality of life in medical student with polycystic ovary syndrome

Rita Saxena, Pooja Singh, Anjana Verma, Manu Sharma


Background: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder affecting 5-10% of women worldwide. It has clinical, hormonal and psychological manifestation like anxiety, depression and low self-esteem. Aim was to evaluate prevalence of anxiety, depression, and quality of life in medical students with PCOS. Objectives were to study the prevalence of anxiety, depression among medical students suffering from PCOS; and to evaluate quality of life (QoL) in students with PCOS and its association with anxiety, depression and quality of life.

Methods: The cross sectional study was conducted among 70 medical students at Geetanjali Medical College and Hospital, Udaipur, Rajasthan, from February 2019 – June 2020. Students were screened and selected as per the Rotterdam’s 2003 criteria after informed consent. Mental health assessment done by using Hamilton depression rating scale for depression, Hamilton anxiety rating scale for anxiety, and using 36-item short form survey for QoL.

Results: Twenty five (35.7%) students suffered from anxiety while 20 (28.5%) had depressive disorders. Forty five (64%) patient both anxiety and depression. These students had significant psychological morbidity and poor QoL.

Conclusions: Psychological morbidity with PCOS is undertreated and need to be addressed and treated in time so as to turn these students into a responsible happy adult.


PCOS, Anxiety, Depression, Quality of life

Full Text:



Dargham SR, Ahmed L, Kilpatrick ES, Atkin SL. The prevalence and metabolic characteristics of polycystic ovary syndrome in the Qatari population. PloS One. 2017;12:e0181467.

Matzke A. The Underdiagnosis of Polycystic Ovarian Syndrome in Normal Weight Adolescent Females [Dissertation]. Minneapolis: St. Catherine University. 2011.

Joseph N, Reddy AG, Joy D, Patel V, Santhosh P, Das S, et al. Study on the proportion and determinants of polycystic ovarian syndrome among health sciences students in South India. J Nat Sc Biol Med. 2016;7:166-72.

Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19-25.

Teede HJ, Misso ML, Deeks AA, Moran LJ, Stuckey BG, Wong JL, et al. Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline. Med J Aust. 2011;195:65-112.

Alvarez-Blasco F, Botella-Carretero JI, San Millán JL, Escobar-Morreale HF. Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women. Arch Intern Med. 2006;166:2081-6.

Chen TH, Lu RB, Chang AJ, Chu DM, Chou KR: The evaluation of cognitive-behavioral group therapy on patient depression and self-esteem. Arch Psychiatr Nurs. 2006;20:3-11.

Deeks AA, Gibson-Helm ME, Teede HJ. Anxiety and depression in polycystic ovary syndrome: a comprehensive investigation. Fertil Steril. 2010;93:2421-3.

Michelmore KF. Polycystic ovary syndrome in adolescence and early adulthood. Hum Fertil (Camb). 2000;3:96-100.

Coffey S, Bano G, Mason HD: Health-related quality of life in women with polycystic ovary syndrome: a comparison with the general population using the Polycystic Ovary Syndrome Questionnaire (PCOSQ) and the Short Form-36 (SF-36). Gynecol Endocrinol. 2006;22:80-6.

Murri M, Luque-Ramírez M, Insenser M, Ojeda-Ojeda M, Escobar-Morreale HF. "Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis". Hum Reprod Update. 2013;19(3):268-88.

Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.

Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:50-5.

Lins L, Carvalho FM. SF-36 total score as a single measure of health-related quality of life: Scoping review. SAGE Open Med. 2016;4:2050312116671725.

Barry JA, Kuczmierczyk AR, Hardiman PJ. Anxiety and depression in polycystic ovary syndrome: A systematic review and meta-analysis. Hum Reprod. 2011;26:2442-51.

Veltman-Verhulst SM, Boivin J, Eijkemans MJ, Fauser BJ. Emotional distress is a common risk in women with polycystic ovary syndrome: A systematic review and meta-analysis of 28 studies. Hum Reprod Update. 2012;18:638-51.

Hussain A, Chandel RK, Ganie MA, Dar MA, Rather YH, Wani ZA, et al. Prevalence of psychiatric disorders in patients with a diagnosis of polycystic ovary syndrome in Kashmir. Indian J Psychol Med. 2015;37:66-70.

Cooney LG, Lee I, Sammel MD, Dokras A. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: A systematic review and meta-analysis. Hum Reprod. 2017;32:1075-91.

Deeks AA, Gibson-Helm ME, Paul E, Teede HJ. Is having polycystic ovary syndrome a predictor of poor psychological function including anxiety and depression? Hum Reprod. 2011;26:1399-407.

Sayyah-Melli M, Alizadeh M, Pourafkary N, Ouladsahebmadarek E, Jafari-Shobeiri M, Abbassi J, et al. Psychosocial factors associated with polycystic ovary syndrome: A Case control study. J Caring Sci. 2015;4:225-31.

Barnard L, Ferriday D, Guenther N, Strauss B, Balen AH, Dye L, et al. Quality of life and psychological well-being in polycystic ovary syndrome. Hum Reprod. 2007;22:2279-86.